2 ASX stocks to help turn $100,000 into $1 million

Turning $100,000 into $1 million is the dream. But despite what you might read on social media, it doesn’t happen overnight and it certainly doesn’t happen without risk.

What can help everyday investors reach that milestone, however, is a combination of time, patience, and investments in high-quality ASX stocks that are capable of compounding earnings for many years.

The maths is surprisingly simple: at a 10% average annual return, money doubles roughly every seven years. That means a 10x return is absolutely possible over a 20 to 25-year horizon, but you need to own the right businesses.

With that in mind, listed below are two ASX stocks that stand out today as long-term compounders with the potential to help turn a $100,000 starting balance into something substantially bigger over time.

CSL Ltd (ASX: CSL)

CSL is exactly the kind of stock that investors should own for generational wealth creation. It isn’t flashy, speculative, or volatile. It is a global biotech powerhouse with irreplaceable assets, deep competitive moats, and decades of proven execution.

The company’s plasma-derived therapies and vaccines serve millions of patients worldwide, and demand tends to grow steadily regardless of economic conditions. In addition, CSL continues to invest heavily in R&D to expand its pipeline, while also increasing its US manufacturing footprint to reduce supply-chain risk and support long-term margin recovery.

Although CSL’s share price has struggled in 2025 due to tariff concerns, margin recovery delays, and uncertainty around the Seqirus spin-off, the fundamentals remain exceptionally strong.

More importantly, CSL has the kind of long-term growth engine that investors want when trying to multiply their wealth. Over the past two decades, the company has transformed many investors into millionaires through steady earnings growth and disciplined reinvestment. If it continues compounding at anything close to its historical rate, CSL could be a great holding in a balanced portfolio.

Life360 Inc. (ASX: 360)

Another ASX stock to buy could be Life360. The family safety and location-sharing platform has been delivering exceptional growth in recent years.

This has continued in 2025, with third quarter revenue rising 34% year on year to US$124.5 million. In addition, Annualised Monthly Revenue hit US$446.7 million, up 33%, and Paying Circles climbed to 2.7 million following a record quarter of additions.

Life360 is scaling rapidly across the US and internationally, underpinned by subscription growth, rising average revenue per user and expanding premium features.

With approximately 91.6 million monthly active users and just a fraction currently paying for premium features, Life360 has an enormous runway. If it successfully monetises even a modest portion of its global user base, the long-term earnings potential could be enormous.

The post 2 ASX stocks to help turn $100,000 into $1 million appeared first on The Motley Fool Australia.

More reading

• Macquarie reveals ASX 200 share tips in each market sector for 2026
• Should I buy CSL shares in December?
• My best ASX stocks to invest $2,000 in right now
• Bear market alert: ASX 200 tech shares down 24% since September peak
• 3 amazing ASX growth shares to buy and hold forever

Motley Fool contributor James Mickleboro has positions in CSL and Life360. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.